Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cancer CARE (Connected Access and Remote Expertise) Beyond Walls - Pilot, Phase 2 Clinical Trial to Evaluate Administration of Cancer-Directed Therapy in the Patient's Homes Versus in Clinic in the Florida Panhandle and Surrounding Areas

NCT07285044 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07285044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07285044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cancer CARE (Connected Access and Remote Expertise) Beyond Walls - Pilot, Phase 2 Clinical Trial to Evaluate Administration of Cancer-Directed Therapy in the Patient's Homes Versus in Clinic in the Florida Panhandle and Surrounding Areas
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Recruiting
Start date
December 18, 2025
Completion date
May 15, 2027
Enrollment
27 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis, basal cell carcinoma, biliary tract carcinoma, bladder carcinoma, breast carcinoma, cervical carcinoma, colorectal carcinoma, endometrial carcinoma, fallopian tube carcinoma, gastroesophageal junction carcinoma, glioblastoma, head and neck carcinoma, hematopoietic and lymphatic system neoplasm, hepatocellular carcinoma, hodgkin lymphoma, lung carcinoma, malignant solid neoplasm, mantle cell lymphoma, melanoma, merkel cell carcinoma, multiple myeloma, myelodysplastic syndrome, ovarian carcinoma, pancreatic carcinoma, primary peritoneal carcinoma, prostate carcinoma, renal cell carcinoma, squamous cell carcinoma, urothelial carcinoma